Atossa Therapeutics
ATOS
#9776
Rank
NZ$74.46 M
Marketcap
NZ$8.65
Share price
-0.79%
Change (1 day)
588.98%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.41.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4221.21%
2024NZ-$0.35-16.67%
2023NZ-$0.4114.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.40-2.96%
2019NZ-$3.50-63.09%
2018NZ-$9.49-49.63%
2017NZ-$18.85-57.87%
2016NZ-$44.74-74.01%
2015NZ-$172.11-9.18%
2014NZ-$189.50-12.86%
2013NZ-$217.4670.73%
2012NZ-$127.3734.08%
2011NZ-$95.00263.47%
2010NZ-$26.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.22-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.91-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.69-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.52 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA